Market Research Logo

Next-Generation Sequencing: Emerging Clinical Applications and Global Markets

Next-Generation Sequencing: Emerging Clinical Applications and Global Markets

The global clinical next-generation sequencing (NGS) market was valued at $886.1 million in 2014. This market is expected to grow at a compound annual growth rate (CAGR) of 31.3%, from $997.1 million in 2015 to nearly $3.9 billion by 2020.

This report provides:

An overview of the global market for next-generation sequencing and its emerging clinical applications.

Analyses of global market trends, with data from 2014, estimates for 2015, and projections of CAGRs through 2020.

Examination of the sequencing industry structure for key market segments.

Discussion covering the strategies employed by the main companies in the market.

Comprehensive company profiles of major players in the field.


SCOPE AND FORMAT

The scope of the report includes clinical NGS technologies, applications, industries, initiatives, patents and companies. The markets for NGS-based diagnostics are given for the years 2014, 2015 and 2020.

This report reviews the main sequencing technologies and explains why genetic variation is important in clinical testing. It then discusses some of the top research initiatives that are contributing to clinical NGS applications. Market driving forces are also discussed.

The report examines the markets by test complexity, indication and test purpose. Test complexity refers to the multiplexing (e.g., the number of genes covered) and coverage (e.g., the extent to which the genome is covered) of the test. Examining the market by test complexity provides valuable insight into which products (e.g., sample preparation, NGS instrument, informatics) will be in demand in the future.

The report provides market data and forecasts for NGS diagnostics by specific applications, including those for cancer, rare diseases, complex disorders and reproductive health.

Specific geographic markets are discussed, including North America, Europe, China, Japan and the rest of the world.

Market data covers the years 2014, 2015 and 2020.

Industry sectors analyzed include NGS instruments, target enrichment, informatics, clinical laboratory testing services, reproductive health diagnostics, HLA typing, liquid biopsy, immune sequencing and fusion diagnostics.

More than 170 companies in the clinical NGS industry are profiled in this report.

BCC Research provides a summary of the main industry acquisitions and strategic alliances from 2013 through 2015, including key alliance trends.

CHAPTER 1 INTRODUCTION
STUDY GOALS AND OBJECTIVES
REASONS FOR DOING THE STUDY
CONTRIBUTION OF THE STUDY AND INTENDED AUDIENCE
SCOPE AND FORMAT
METHODOLOGY
INFORMATION SOURCES
ANALYST'S CREDENTIALS
RELATED BCC RESEARCH REPORTS
BCC RESEARCH WEBSITE
DISCLAIMER
CHAPTER 2 EXECUTIVE SUMMARY
SUMMARY TABLE GLOBAL CLINICAL NEXT-GENERATION SEQUENCING MARKET BY DISEASE CLASS, THROUGH 2020 ($ MILLIONS)
SUMMARY FIGURE GLOBAL CLINICAL NEXT-GENERATION SEQUENCING MARKET BY DISEASE CLASS, 2014-2020 ($ MILLIONS)
CHAPTER 3 OVERVIEW
INTRODUCTION
TABLE 1 REPORT SCOPE
CLINICAL NGS MARKETS
TABLE 2 GLOBAL NEXT-GENERATION SEQUENCING DIAGNOSTIC MARKET BY DISEASE TYPE, THROUGH 2020 ($ MILLIONS)
CLINICAL NGS GROWTH DRIVING FORCES
TECHNOLOGY DRIVERS
TABLE 3 KEY TECHNOLOGY DRIVERS FOR CLINICAL NEXT-GENERATION
SEQUENCING
MARKET DRIVERS
TABLE 4 CLINICAL NEXT-GENERATION SEQUENCING MARKET DRIVING
FORCES
CLINICAL NGS APPLICATIONS
TABLE 5 CLINICAL NEXT-GENERATION SEQUENCING APPLICATION STATUS
CLINICAL NGS INDUSTRY
TABLE 6 KEY DIAGNOSTIC NEXT-GENERATION SEQUENCING INDUSTRY
PARTICIPANTS BY SECTOR
CHAPTER 4 TECHNOLOGIES
IMPORTANCE OF DNA
TABLE 7 DNA CHEMICAL BUILDING BLOCKS
TABLE 8 DNA TRANSLATION AND TRANSCRIPTION
TABLE 9 LONG-RANGE DNA STRUCTURE
GENETIC VARIATION AND ANALYSIS
TABLE 10 GENETIC VARIANT TYPES
GENETIC ANALYSIS TECHNOLOGIES
TABLE 11 IMPORTANT MOLECULAR DIAGNOSTIC PLATFORMS
NGS IN CLINICAL APPLICATIONS
TABLE 12 GENETIC TESTING EVOLUTION
TABLE 13 MARKET SEGMENTS FOR NEXT-GENERATION SEQUENCING
DIAGNOSTICS
NGS TECHNOLOGIES
HISTORY OF DNA SEQUENCING
TABLE 14 DNA SEQUENCING HISTORICAL TIMELINE, 1977-2015
TABLE 15 SEQUENCING TECHNOLOGY DEVELOPMENT, 1990-2020
FIGURE 1 EFFECT OF NEW SEQUENCING TECHNOLOGIES ON COST TO SEQUENCE A SINGLE HUMAN GENOME, 2001-2014 [3] ($/GENOME)
SANGER SEQUENCING TECHNOLOGY
TABLE 16 SANGER SEQUENCING SUMMARY
TABLE 17 SANGER SEQUENCING IMPROVEMENTS
NGS PLATFORMS
TABLE 18 NEXT-GENERATION SEQUENCING TECHNOLOGIES
TABLE 19 ROCHE NEXT-GENERATION SEQUENCING WORKFLOW
TABLE 20 ILLUMINA NEXT-GENERATION SEQUENCING WORKFLOW
TABLE 21 LIFE TECHNOLOGIES NEXT-GENERATION SEQUENCING
WORKFLOW
BENCHTOP SEQUENCERS
TABLE 22 BENCHTOP SEQUENCER PLATFORMS
NANOPORE SEQUENCING TECHNOLOGIES
INFORMATICS TECHNOLOGIES
TABLE 23 NEXT-GENERATION SEQUENCING BIOINFORMATICS WORKFLOW
BASE CALLING
MAPPING TO A REFERENCE SEQUENCE
TABLE 24 SEQUENCE ANNOTATION STEPS
VARIANT ANALYSIS
FUTURE TECHNOLOGY CHALLENGES
TABLE 25 FUTURE CHALLENGES FOR IMPLEMENTING CLINICAL
NEXT-GENERATION SEQUENCING
CHAPTER 5 TOP 10 CLINICAL NGS INITIATIVES
TABLE 26 TOP 10 CLINICAL NEXT-GENERATION SEQUENCING PROJECTS
ACTIONABLE GENOME CONSORTIUM
BABYSEQ
CANCER MOON SHOTS PROGRAM
CLINGEN
LUNG-MAP
MATCHMAKER EXCHANGE
MILLION VETERAN PROGRAM
MEDSEQ
PRECISION MEDICINE
PROMPT
CHAPTER 6 CLINICAL NGS APPLICATIONS
INTRODUCTION
TABLE 27 CLINICAL NEXT-GENERATION SEQUENCING, NEAR TO MID-TERM
APPLICATIONS
CANCER APPLICATIONS
TABLE 28 CANCER APPLICATIONS
MENDELIAN DISORDERS APPLICATIONS
TABLE 29 MENDELIAN DISORDERS APPLICATIONS
REPRODUCTIVE HEALTH APPLICATIONS
TABLE 30 SCREENING APPLICATIONS
TABLE 31 ETHICAL ISSUES ASSOCIATED WITH PRENATAL AND NEWBORN
SCREENING
INFECTIOUS DISEASE APPLICATIONS
TABLE 32 INFECTIOUS DISEASE APPLICATIONS
COMPLEX DISORDERS APPLICATIONS
TABLE 33 COMPLEX DISORDER APPLICATIONS
CHAPTER 7 CLINICAL NGS INDUSTRY
INTRODUCTION
TABLE 34 KEY SEGMENTS WITHIN THE NEXT-GENERATION SEQUENCING
CLINICAL INDUSTRY
NGS INSTRUMENT INDUSTRY
TABLE 35 NEXT-GENERATION SEQUENCING INSTRUMENT COMPANIES
SUMMARY
NGS TARGET ENRICHMENT INDUSTRY
TABLE 36 NEXT-GENERATION SEQUENCING-BASED TARGET ENRICHMENT
INDUSTRY
NGS CLINICAL INFORMATICS INDUSTRY
TABLE 37 NEXT-GENERATION SEQUENCING CLINICAL INFORMATICS
COMPANY POSITIONING
NGS CLINICAL LABORATORY TESTING SERVICES INDUSTRY
TABLE 38 NGS CLINICAL LABORATORY TESTING SERVICES INDUSTRY
INDIA'S CLINICAL SEQUENCING INDUSTRY
TABLE 39 INDIA NGS CLINICAL SEQUENCING COMPETITIVE POSITIONING
REPRODUCTIVE HEALTH DIAGNOSTICS INDUSTRY
NONINVASIVE PRENATAL TESTING INDUSTRY
TABLE 40 NGS NIPT INDUSTRY
TABLE 41 GLOBAL NGS-BASED NONINVASIVE PRENATAL DIAGNOSTIC MARKET SHARE BY TEST, 2014 (%)
TABLE 42 GERMANY NGS-BASED NONINVASIVE PRENATAL DIAGNOSTIC COMPETITIVE SITUATION
PREIMPLANTATION GENETICS DIAGNOSIS/SCREENING INDUSTRY
TABLE 43 PREIMPLANTATION DIAGNOSTICS PLATFORMS
TABLE 44 PREIMPLANTATION GENETIC SCREENING AND DIAGNOSIS
INDUSTRY
LIQUID BIOPSY INDUSTRY
TABLE 45 NGS-BASED LIQUID BIOPSY INDUSTRY
HLA TYPING INDUSTRY
TABLE 46 NGS-BASED HLA TYPING INDUSTRY COMPETITORS
IMMUNE SEQUENCING INDUSTRY
TABLE 47 IMMUNE SYSTEM PROFILING INDUSTRY
NGS GENE FUSION DIAGNOSTICS INDUSTRY
TABLE 48 NGS-BASED GENE FUSION DIAGNOSTICS INDUSTRY
CLINICAL NGS INDUSTRY ACQUISITIONS AND STRATEGIC ALLIANCES
ACQUISITIONS
TABLE 49 CLINICAL NEXT-GENERATION SEQUENCING INDUSTRY ACQUISITIONS, 2013- MARCH 2015
STRATEGIC ALLIANCES
TABLE 50 CLINICAL NEXT-GENERATION SEQUENCING STRATEGIC ALLIANCES, 2013-MARCH 2015
CHAPTER 8 NGS DIAGNOSTICS MARKETS
GROWTH DRIVING FORCES
TABLE 51 CLINICAL NEXT-GENERATION SEQUENCING KEY GROWTH DRIVING FORCES, THROUGH 2020
TABLE 52 CLINICAL NGS STAKEHOLDERS ACTIVITY
GLOBAL NGS DIAGNOSTIC MARKET
TABLE 53 GLOBAL NEXT-GENERATION SEQUENCING DIAGNOSTIC MARKET BY TEST COMPLEXITY, THROUGH 2020 ($ MILLIONS)
TABLE 54 GLOBAL NEXT-GENERATION SEQUENCING DIAGNOSTIC MARKET BY TEST PURPOSE, THROUGH 2020 ($ MILLIONS)
NGS CANCER DIAGNOSTIC MARKETS
TABLE 55 GLOBAL NEXT-GENERATION SEQUENCING CANCER DIAGNOSTIC MARKET BY SEGMENT, THROUGH 2020 ($ MILLIONS)
TABLE 56 GLOBAL NEXT-GENERATION SEQUENCING CANCER DIAGNOSTIC MARKET BY TEST PURPOSE, THROUGH 2020 ($ MILLIONS)
NGS Cancer Diagnosis Market
NGS Cancer Screening Market
NGS Cancer Monitoring Market
NGS Cancer Therapy Guidance Market
Companion Diagnostics
TABLE 57 RECENT NGS-BASED COMPANION DIAGNOSTICS ACTIVITIES
Thyroid and Leukemia Update
NGS Cancer Market by Test Complexity
TABLE 58 GLOBAL CANCER NEXT-GENERATION SEQUENCING DIAGNOSTIC MARKET BY TEST COMPLEXITY, THROUGH 2020 ($ MILLIONS)
TABLE 59 MULTI-GENE NGS-BASED HEMATOLOGICAL TESTS
NGS CARDIOLOGY DIAGNOSTIC MARKETS
TABLE 60 GLOBAL NEXT-GENERATION SEQUENCING CARDIOVASCULAR DIAGNOSTIC MARKET BY TEST PURPOSE, THROUGH 2020 ($ MILLIONS)
TABLE 61 DILATED CARDIOMYOPATHY TEST PROVIDERS
TABLE 62 GLOBAL NEXT-GENERATION SEQUENCING CARDIOLOGY DIAGNOSTIC MARKET BY TEST COMPLEXITY, THROUGH 2020 ($ MILLIONS)
NGS MENDELIAN DISORDERS DIAGNOSTIC MARKETS
TABLE 63 GLOBAL NEXT-GENERATION SEQUENCING MENDELIAN DISORDER DIAGNOSTIC MARKET BY TEST PURPOSE, THROUGH 2020 ($ MILLIONS)
TABLE 64 GLOBAL NEXT-GENERATION SEQUENCING MENDELIAN DISORDER DIAGNOSTIC MARKET BY TEST COMPLEXITY, THROUGH 2020 ($ MILLIONS)
NGS METABOLIC/IMMUNE DISORDER DIAGNOSTIC MARKETS
TABLE 65 GLOBAL NEXT-GENERATION SEQUENCING METABOLIC AND IMMUNE DISORDER DIAGNOSTIC MARKET BY TEST PURPOSE, THROUGH 2020 ($ MILLIONS)
TABLE 66 MULTIPLE SCLEROSIS DIAGNOSTIC TECHNOLOGIES
TABLE 67 GLOBAL NEXT-GENERATION SEQUENCING METABOLIC AND IMMUNE DISORDER DIAGNOSTIC MARKET BY TEST COMPLEXITY, THROUGH 2020 ($ MILLIONS)
NGS NEUROLOGY DIAGNOSTIC MARKETS
TABLE 68 GLOBAL NEXT-GENERATION SEQUENCING NEUROLOGY DIAGNOSTIC MARKET BY TEST PURPOSE, THROUGH 2020 ($ MILLIONS)
TABLE 69 GLOBAL NEXT-GENERATION SEQUENCING NEUROLOGY DIAGNOSTIC MARKET BY TEST COMPLEXITY, THROUGH 2020 ($ MILLIONS)
NGS REPRODUCTIVE HEALTH DIAGNOSTIC MARKETS
Newborn Screening Diagnostic Market
TABLE 70 GLOBAL NEXT-GENERATION SEQUENCING NEWBORN SCREENING DIAGNOSTIC MARKET BY TEST PURPOSE, THROUGH 2020 ($ MILLIONS)
TABLE 71 GLOBAL NEXT-GENERATION SEQUENCING NEWBORN SCREENING DIAGNOSTIC MARKET BY TEST COMPLEXITY, THROUGH 2020 ($ MILLIONS)
Prenatal Screening Diagnostic Market
TABLE 72 GLOBAL NEXT-GENERATION SEQUENCING PRENATAL DIAGNOSTIC MARKET BY TEST PURPOSE, THROUGH 2020 ($ MILLIONS)
TABLE 73 GLOBAL NEXT-GENERATION SEQUENCING PRENATAL DIAGNOSTIC MARKET BY TEST COMPLEXITY, THROUGH 2020 ($ MILLIONS)
Preimplantation Diagnostic Market
TABLE 74 GLOBAL NEXT-GENERATION SEQUENCING PREIMPLANTATION DIAGNOSTIC MARKET BY TEST PURPOSE, THROUGH 2020 ($ MILLIONS)
TABLE 75 GLOBAL NEXT-GENERATION SEQUENCING PREIMPLANTATION DIAGNOSTIC MARKET BY TESTmCOMPLEXITY, THROUGH 2020 ($ MILLIONS)
NGS FOOD-BORNE ILLNESS DIAGNOSTIC MARKET
TABLE 76 GLOBAL NEXT-GENERATION SEQUENCING FOOD-BORNE ILLNESS DIAGNOSTIC MARKET BY TEST PURPOSE, THROUGH 2020 ($ MILLIONS)
TABLE 77 GLOBAL NEXT-GENERATION SEQUENCING FOOD-BORNE ILLNESS DIAGNOSTIC MARKET BY TEST COMPLEXITY, THROUGH 2020 ($ MILLIONS)
TABLE 78 NGS IN INFECTIOUS DISEASE DIAGNOSTICS
NGS HLA TYPING DIAGNOSTIC MARKET
TABLE 79 GLOBAL NEXT-GENERATION SEQUENCING HLA TYPING DIAGNOSTIC MARKET BY TEST PURPOSE, THROUGH 2020 ($MILLIONS)
TABLE 80 GLOBAL NEXT-GENERATION SEQUENCING HLA TYPING DIAGNOSTIC MARKET BY TEST COMPLEXITY, THROUGH 2020 ($MILLIONS)
NGS DIAGNOSTIC MARKETS BY REGION
TABLE 81 GLOBAL NEXT-GENERATION SEQUENCING DIAGNOSTIC MARKET BY REGION, THROUGH 2020 ($ MILLIONS)
NORTH AMERICA
TABLE 82 NORTH AMERICAN NEXT-GENERATION SEQUENCING DIAGNOSTIC MARKET BY APPLICATION, THROUGH 2020 ($MILLIONS)
EUROPE
TABLE 83 EUROPEAN NEXT-GENERATION SEQUENCING DIAGNOSTIC MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
CHINA
TABLE 84 CHINA NEXT-GENERATION SEQUENCING DIAGNOSTIC MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
JAPAN
TABLE 85 JAPANESE NEXT-GENERATION SEQUENCING DIAGNOSTIC MARKET BY APPLICATION, THROUGH 2020 ($ MILLIONS)
REST OF WORLD
TABLE 86 REST OF WORLD NEXT-GENERATION SEQUENCING DIAGNOSTIC MARKET BY APPLICATION, THROUGH 2020 ($MILLIONS)
CHAPTER 9 PATENTS
CLINICAL NGS PATENTS
TABLE 87 CLINICAL NEXT-GENERATION SEQUENCING PATENTS, 004-2014
CLINICAL NGS PATENTS BY INDICATION
TABLE 88 CLINICAL NEXT-GENERATION SEQUENCING PATENTS BY INDICATION, 2004-2014
STATUS OF MYRIAD'S BRCA PATENTS
SEQUENOM AND ILLUMINA NIPT PATENT POOL
CHAPTER 10 COMPANY PROFILES
10X GENOMICS
14M GENOMICS LTD.
23ANDME INC.
TABLE 89 DATA NEEDS
ADAPTIVE BIOTECHNOLOGIES INC.
ADMERA HEALTH
AGILENT TECHNOLOGIES INC.
ALMAC GROUP LTD.
AMARANTUS BIOSCIENCE HOLDINGS INC.
AMBRY GENETICS
APPISTRY INC.
ARUP LABORATORIES
ASSUREX HEALTH
ASTRIDBIO TECHNOLOGIES KFT.
ASURAGEN INC.
ATHENA DIAGNOSTICS INC.
ATRECA INC.
BASE4 INNOVATION LTD.
BAYLOR MIRACA GENETICS LABORATORIES INC.
BECTON, DICKINSON AND CO.
BERRY GENOMICS CO. LTD.
BGI SHENZHEN
BIOARRAY SL
BIODESIX INC.
BIOINNOVATION SOLUTIONS SA
BIO-RAD LABORATORIES INC.
BIOTHERANOSTICS INC.
BLUEPRINT GENETICS
BOREAL GENOMICS
CAREDX INC.
CARIS LIFE SCIENCES
CEGAT GMBH
CELLULAR RESEARCH INC.
CENTOGENE AG
CERGENTIS BV
CHRONIX BIOMEDICAL
CLARITAS GENOMICS INC.
CLEVELAND CLINICAL LABORATORIES
COFACTOR GENOMICS INC.
CORIELL LIFE SCIENCES INC.
CORRELAGEN DIAGNOSTICS INC.
COUNSYL INC.
COURTAGEN LIFE SCIENCES INC.
CYNVENIO BIOSYSTEMS INC.
CYPHER GENOMICS INC.
DANAHER CORP.
DIPLOID
DIRECTED GENOMICS LLC
DNA ELECTRONICS LTD.
DNA LINK INC.
DNANEXUS INC.
ELECTRONIC BIOSCIENCES
ESPERITE NV
EUROFINS GENOMICS
EXOSOME DIAGNOSTICS INC.
EXPRESSION ANALYSIS INC.
FOUNDATION MEDICINE
FUSION GENOMICS CORP.
GATC BIOTECH AG
GE HEALTHCARE
GENAPSYS INC.
GENDX BV
GENE BY GENE LTD.
GENEDX INC.
GENEPEEKS INC.
GENOLOGICS LIFE SCIENCES SOFTWARE
GENOMATIX SOFTWARE GMBH
GENOMEDX
GENOMEQUEST INC.
GENOMIC EXPRESSION
GENOMIC HEALTH INC.
GENOMONCOLOGY
GENOSPACE
GIGAGEN INC.
GOLDEN HELIX
GOOD START GENETICS INC.
HISTOGENETICS LLC
HTG MOLECULAR DIAGNOSTICS INC.
ILLUMINA INC.
TABLE 90 NEW PLATFORMS INTRODUCED BY ILLUMINA IN 2015
INNOVATIONS EXCHANGE PTE. LTD.
INTELLIMEDIX
INTERPACE DIAGNOSTICS LLC
INVITAE
INVIVOSCRIBE TECHNOLOGIES INC.
IREPERTOIRE INC.
KAILOS GENETICS
KELLBENX INC.
KEW GROUP INC.
KNOME INC.
LABORATORY CORPORATION OF AMERICA INC.
LABORATORY FOR MOLECULAR MEDICINE
LASERGEN INC.
LEUCINE RICH BIO
LIFECODE INC.
LUMENOGIX INC.
MACROGEN INC.
MAVERIX BIOMICS INC.
MAYO MEDICAL LABORATORIES
MEDGENOME LABS PVT. LTD.
MEDICAL DIAGNOSTIC LABORATORIES LLC
MEDOMICS LLC
MERCK KGAA
MIRATI THERAPEUTICS
MOGENE CLINICAL DIAGNOSTICS
MOLECULAR HEALTH GMBH
MOLECULARMD CORP.
MRIGLOBAL RESEARCH INSTITUTE
MULTIPLICOM NV
MYRIAD GENETICS INC.
NABSYS INC.
NANTHEALTH
NATERA INC.
NEOGENOMICS INC.
NEW ENGLAND BIOLABS
NEWGENE LTD.
NEW ONCOLOGY AG
N-OF-ONE INC.
NOVARTIS AG
NUGEN TECHNOLOGIES INC.
OMICIA INC.
OMIXON BIOCOMPUTING KFT
ONCODNA SA
OXFORD GENE TECHNOLOGY
OXFORD NANOPORE TECHNOLOGIES LTD.
PACIFIC BIOSCIENCES OF CALIFORNIA INC.
PARABASE GENOMICS
PARSEQ LAB
PATHOGENETIX
PATHWAY GENOMICS CORP.
PERKINELMER INC.
PERSONAL GENOME DIAGNOSTICS INC.
PERSONAL GENOMICS INC.
PERSONALIS INC.
PICOSEQ
POPULATION GENETICS TECHNOLOGIES LTD.
TABLE 91 SENSITIVITY TO DETECT DRUG RESISTANT MUTATIONS IN VIRUSES (%)
PORTABLE GENOMICS LLC
PREMAITHA HEALTH PLC
PRENETICS
PRESSURE BIOSCIENCES INC.
PREVENTIONGENETICS INC.
QIAGEN NV
QUANTAPORE INC.
QUANTUMDX GROUP
QUEST DIAGNOSTICS
RAINDANCE TECHNOLOGIES INC.
REAL TIME GENOMICS INC.
REPROGENETICS
RESPONSE GENETICS INC.
ROCHE HOLDING AG
TABLE 92 COMMERCIAL SEQUENCER COMPETITIVE POSITIONING
ROSWELL PARK CANCER INSTITUTE
SCIGENOM LABS
SELAH GENOMICS
SENGENICS INTERNATIONAL PTE LTD.
SEQUENOM INC.
SEVEN BRIDGES GENOMICS INC.
SISTEMAS GENOMICOS SL
SOFTGENETICS LLC
SOPHIA GENETICS
STATION X INC.
STRAND LIFE SCIENCES
STRATOS GENOMICS INC.
SUNDANCE DIAGNOSTICS INC.
SUPRATECH MICROPATH LABORATORY & RESEARCH INSTITUTE
SYAPSE
SYMBIODX
THERMO FISHER SCIENTIFIC INC.
TRANSGENOMIC INC.
TROVAGENE INC.
VELA DIAGNOSTICS
WAFERGEN BIOSYSTEMS INC.
TABLE 93 WAFERGEN STRATEGIC ALLIANCES
WARP DRIVE BIO LLC
YIKON GENOMICS CO. LTD.
ZS GENETICS INC.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report